Azetidine → HCID 123897862, compound
Reaction equation
Br[C:2]1[N:6]=[C:5]([CH:7]=[CH:8][C:9]2[N:19]=[C:12]3[C:13]([CH3:18])=[N:14][CH:15]=[C:16]([CH3:17])[N:11]3[N:10]=2)[N:4]([CH3:20])[N:3]=1.[O-]C1C=CC=CC=1.[Na+].C1(P(C2C=CC=CC=2)C2C3OC4C(=CC=CC=4P(C4C=CC=CC=4)C4C=CC=CC=4)C(C)(C)C=3C=CC=2)C=CC=CC=1.[NH:71]1[CH2:74][CH2:73][CH2:72]1>O1CCOCC1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd].C(Cl)(Cl)Cl>[N:71]1([C:2]2[N:6]=[C:5]([CH:7]=[CH:8][C:9]3[N:19]=[C:12]4[C:13]([CH3:18])=[N:14][CH:15]=[C:16]([CH3:17])[N:11]4[N:10]=3)[N:4]([CH3:20])[N:3]=2)[CH2:74][CH2:73][CH2:72]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 2-(2-(3-bromo-1-methyl-1H-1,2,4-triazol-5-yl)vinyl)-5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazine (28 mg, 83.8 μmol, Eq: 1.00) in dioxane (1 ml) was purged with argon, then sodium phenoxide (14.6 mg, 126 μmol, Eq: 1.5), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (xant-phos) (3.88 mg, 6.7 μmol, Eq: 0.08), tris(dibenzylideneacetone)dipalladium chloroform complex/Pd2(dba)3CHCl3 (3.47 mg, 3.35 μmol, Eq: 0.04) and azetidine (9.57 mg, 11.3 μl, 168 μmol, Eq: 2) were added. The vial was capped and irradiated at 140° C. for 30 minutes in the microwave oven. The crude material was applied on silicagel and purified by chromatography over a 5 g silicagel column using ethyl acetate/methanol 0-10% as eluent affording 2-[2-(5-azetidin-1-yl-2-methyl-2H-[1,2,4]triazol-3-yl)-vinyl]-5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazine (4 mg/15.4%) as a light yellow solid. MS: m/e=311.4 (M+H+)
Workup
- customThe vial was capped
- customirradiated at 140° C. for 30 minutes in the microwave oven
- custompurified by chromatography over a 5 g silicagel column
Sources & evidence
- ORD record
- ord-d106a6ce17f24035810edb9c2cd512b0
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09394311B2
Reaction notes
Loading…